Moreover, STAT5 is activated in a high percentage of clinical metastatic tumors, and activation of STAT5 in DU145 prostate carcinoma cells has been shown to cause substantially increased formation of experimental metastatic lung tumors [27]. The gene discussed is STAT5A; the disease is metastatic neoplasm.